Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatinib or With Regorafenib For UHCC After Failure of First-line Treatment
Clinical trial NCT07537985 · COMPLETED
Trial details
- NCT number
- NCT07537985
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2025-08-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.